FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy
The VEGF inhibitor is already approved for neovascular (wet) age-related macular degeneration, macular edema after central retinal vein occlusion, and diabetic macular edema.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 15, 2019 Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news

EMA Panel Backs Triple Therapy Inhaler for COPD EMA Panel Backs Triple Therapy Inhaler for COPD
Temybric Ellipta combines fluticasone furoate, umeclidinium, and vilanterol in a single inhaler and is for maintenance treatment of moderate-to-severe COPD.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 27, 2019 Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Alert Source Type: news

EU Panel Backs Dolutegravir/Lamivudine Combo Pill for HIV EU Panel Backs Dolutegravir/Lamivudine Combo Pill for HIV
Dovato contains 50 mg dolutegravir and 300 mg lamivudine and would be the first once-daily, single-pill, completed 2-drug regimen for treatment of HIV in Europe.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 27, 2019 Category: Drugs & Pharmacology Tags: HIV/AIDS News Alert Source Type: news

FDA Clears Plenity Hydrogel Capsules for Weight Management FDA Clears Plenity Hydrogel Capsules for Weight Management
The FDA has cleared Gelesis100 for weight management in adults with a body mass index of 25 – 40 kg/m2, when used together with diet and exercise.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 17, 2019 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news

Drug Shortages Have Small Effect on Outpatient Cancer Care Drug Shortages Have Small Effect on Outpatient Cancer Care
In the outpatient setting, drug shortages have had little effect on chemotherapy treatment among adults with common cancers, say investigators.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 15, 2019 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

Beware Drug Interactions With Supplements Beware Drug Interactions With Supplements
Certain supplements may have serious interactions with medications. Do you know which supplements your patients are taking?Medscape Pharmacists (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 9, 2019 Category: Drugs & Pharmacology Tags: Pharmacist Commentary Source Type: news

FDA OKs Reintroduction of Tegaserod for IBS-C in Women Under 65 FDA OKs Reintroduction of Tegaserod for IBS-C in Women Under 65
The FDA will allow tegaserod back on the market after an advisory committee recommended its use in women without a history of CV ischemic disease.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 3, 2019 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news

Local Leaders Back Narcan to Stop Overdose Deaths Local Leaders Back Narcan to Stop Overdose Deaths
A surge in opioid overdose deaths prompted 49 states and the District of Columbia to offer Narcan without a prescription. CDC data showed that nearly 48,000 people died from opioid overdose in 2017.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 2, 2019 Category: Drugs & Pharmacology Tags: Emergency Medicine News Source Type: news

FDA Approves Cladribine (Mavenclad) for Relapsing MS FDA Approves Cladribine (Mavenclad) for Relapsing MS
The US Food and Drug Administration today approved cladribine for treatment of patients with relapsing multiple sclerosis who have had insufficient response to other agents.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 30, 2019 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Alert Source Type: news

FDA Approves Siponimod (Mayzent) for Multiple Sclerosis FDA Approves Siponimod (Mayzent) for Multiple Sclerosis
The agency has approved a new oral agent for relapsing forms of multiple sclerosis, including clinically isolated syndrome and secondary progressive disease.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 27, 2019 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Alert Source Type: news

Drug Addiction Stigma Is Like Old Cancer Stigma Drug Addiction Stigma Is Like Old Cancer Stigma
Physicians who judge patients who have substance use disorders might want to reflect on the past stigmatization of cancer, says a cancer specialist.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 25, 2019 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

Phone Intervention for Patients Most At Risk Improves HbA1c Phone Intervention for Patients Most At Risk Improves HbA1c
Pharmacist-led phone interventions to improve insulin adherence in patients with diabetes worked best when those at highest risk of noncompliance were targeted.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 18, 2019 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

OTC Insomnia Supplements: The Latest Evidence OTC Insomnia Supplements: The Latest Evidence
Dietary supplements are used by millions of people seeking a good night's sleep, but which ones are safe and effective?Medscape Pharmacists (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 15, 2019 Category: Drugs & Pharmacology Tags: Pharmacist Ask the Expert Source Type: news

FDA OKs Rocklatan, a New Once-Daily Eye Drop for Glaucoma FDA OKs Rocklatan, a New Once-Daily Eye Drop for Glaucoma
The netarsudil and latanoprost ophthalmic solution (Rocklatan) reduces elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 14, 2019 Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news

FDA Commissioner Scott Gottlieb Resigning FDA Commissioner Scott Gottlieb Resigning
The FDA chief has focused much of his energy on regulating e-cigarettes, calling vaping a scourge among American teenagers.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 5, 2019 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Alert Source Type: news

Allow Docs to Recycle Chemo Pills, Already Allow Docs to Recycle Chemo Pills, Already
Currently, some physicians take discarded oral cancer drugs from one patient and pass them on to another, but the activity occurs in a legally murky zone.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 9, 2019 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

Liquid Biopsy Tracks Herceptin Resistance in HER2+ Gastric Cancer Liquid Biopsy Tracks Herceptin Resistance in HER2+ Gastric Cancer
Circulating tumor DNA profiling can provide novel insights into gene alterations that underlie trastuzumab resistance in HER2+ metastatic gastric cancer.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 27, 2018 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

Treatment Response Foretells Events in Breast Cancer Treatment Response Foretells Events in Breast Cancer
A pathological complete response to neoadjuvant therapy is a harbinger of an excellent prognosis for most tumor types in breast cancer.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 6, 2018 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

FDA Approves New Oral Drug for AML FDA Approves New Oral Drug for AML
Pfizer's Daurismo Improves Overall Survival in Newly Diagnosed Patients Aged 75+FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 21, 2018 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Alert Source Type: news

CAM Popular, but Cancer Patients Unaware of Risks CAM Popular, but Cancer Patients Unaware of Risks
Two studies involving sarcoma patients show that complementary and alternative medicine (CAM) treatments are popular, and most patients seem to be unconcerned about risks, such as interactions.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 12, 2018 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

FDA Clears Pluristem Radiation Treatment for Emergency Use FDA Clears Pluristem Radiation Treatment for Emergency Use
Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug Administration has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 1, 2018 Category: Drugs & Pharmacology Tags: Pharmacist News Alert Source Type: news

Are Pharmacists Your Competitors or Your Collaborators? Are Pharmacists Your Competitors or Your Collaborators?
As physicians struggle to keep up with demand for their services, pharmacists are picking up some of that business. Many physicians are comfortable with this, but others feel differently.Medscape Business of Medicine (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 12, 2018 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care Article Source Type: news

MS: New Dosing, A New Withdrawal MS: New Dosing, A New Withdrawal
Cutting the risk for natalizumab-related PML, update on disability outcomes with ibudilast, and daclizumab pulled from the global market.Medscape Neurology (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 5, 2018 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Commentary Source Type: news

Trump Budget Ups Funds to Fight Opioids, Cuts HHS Trump Budget Ups Funds to Fight Opioids, Cuts HHS
The budget takes a four-pronged approach, according to the new HHS secretary, with the fight against opioid abuse gaining some funding, while other departments may take some hits for 2019.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 13, 2018 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Source Type: news

Influenza Hospitalizations Highest on Record, CDC Says Influenza Hospitalizations Highest on Record, CDC Says
Overall hospitalizations for influenza-like illness are at their highest since the CDC began collecting such data, and the season has yet to peak, according to new government information.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 2, 2018 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

New HHS Division to Protect Clinicians With Religious Objections New HHS Division to Protect Clinicians With Religious Objections
The Trump administration opens the new unit within HHS to focus on claims of coercion on medical staff to perform abortions and other procedures over religious objections.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 19, 2018 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news

U.S. City Mayors Stand Up for Cannabis Against Trump Crackdown U.S. City Mayors Stand Up for Cannabis Against Trump Crackdown
Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 17, 2018 Category: Drugs & Pharmacology Tags: Public Health & Prevention News Source Type: news

EMA Updates Contraception Advice Around Mycophenolate EMA Updates Contraception Advice Around Mycophenolate
When a male patient has taken mycophenolate, either he or his female partner should use reliable contraception; it is no longer required that they both use contraception, the EMA now advises.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 18, 2017 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news

HIV Drug Raltegravir Approved for Neonates HIV Drug Raltegravir Approved for Neonates
Raltegravir is the only integrase inhibitor approved in the US for treatment of HIV in newborns from birth to 4 weeks of age weighing at least 2 kg.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 12, 2017 Category: Drugs & Pharmacology Tags: HIV/AIDS News Alert Source Type: news

CHMP Backs Two Pan-Genotypic Antivirals for Hep C CHMP Backs Two Pan-Genotypic Antivirals for Hep C
Maviret and Vosevi were evaluated under the European Union's accelerated assessment, which speeds access to new medicines where there is an unmet medical need.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 23, 2017 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news

Senate Unveils Bill to Repeal and Replace ACA Senate Unveils Bill to Repeal and Replace ACA
Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 22, 2017 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Alert Source Type: news

Senate Confirms Scott Gottlieb, MD, as FDA Chief Senate Confirms Scott Gottlieb, MD, as FDA Chief
Dr Gottlieb brings an impressive resume to his new job, but his extensive experience in an industry he will regulate continues to raise questions about conflicts of interest.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 10, 2017 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Alert Source Type: news

FDA Approves Edaravone (Radicava) for ALS FDA Approves Edaravone (Radicava) for ALS
The FDA"rapidly engaged" the drug's manufacturer to apply for approval here after learning about its use in Japan.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 6, 2017 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Alert Source Type: news

Antihypertensives May Cut Glaucoma Risk Antihypertensives May Cut Glaucoma Risk
A Danish Registry analysis looked at the cases of thousands of patients, but potential limitations weaken its conclusion.Medscape Ophthalmology (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 5, 2017 Category: Drugs & Pharmacology Tags: Ophthalmology Viewpoint Source Type: news

FDA Clears Abaloparatide for High-Risk Osteoporosis Patients FDA Clears Abaloparatide for High-Risk Osteoporosis Patients
Abaloparatide is the first new anabolic treatment approved for postmenopausal women with osteoporosis in the United States in nearly 15 years.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 28, 2017 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

CHMP Backs Orphan Hybrid Drug for Wilson's Disease CHMP Backs Orphan Hybrid Drug for Wilson's Disease
Trientine tetrahydrochloride (Cuprior) is indicated for treatment of Wilson's disease in adults, adolescents, and children aged 5 years and older who are intolerant to D-penicillamine.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 25, 2017 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news

Don't Use Tramadol and Codeine in Kids Under 12, FDA Warns Don't Use Tramadol and Codeine in Kids Under 12, FDA Warns
The two opioids pose the risk for potentially fatal respiratory depression in young children. The FDA also is restricting their use in older children.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 20, 2017 Category: Drugs & Pharmacology Tags: Pediatrics News Alert Source Type: news

HIV Pioneer Mark Wainberg, PhD, Dies Unexpectedly HIV Pioneer Mark Wainberg, PhD, Dies Unexpectedly
News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 12, 2017 Category: Drugs & Pharmacology Tags: HIV/AIDS News Alert Source Type: news

Stopping the Pain: Naltrexone for Self-injurious Behavior Stopping the Pain: Naltrexone for Self-injurious Behavior
Is oral naltrexone an effective pharmacologic option in the treatment and reduction of self-harm?Medscape Pharmacists (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 10, 2017 Category: Drugs & Pharmacology Tags: Pharmacist Ask the Expert Source Type: news

Global EpiPen Recall Now Includes United States Global EpiPen Recall Now Includes United States
A defective part may prevent the device from injecting a potentially life-saving dose of epinephrine for patients experiencing anaphylactic shock, according to the FDA.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 1, 2017 Category: Drugs & Pharmacology Tags: Allergy & Clinical Immunology News Alert Source Type: news

Poppy Seed Tea: Beware This Beverage Poppy Seed Tea: Beware This Beverage
For centuries, poppy seed tea has been used for its narcotic, analgesic, antidiarrheal, or euphoric effects, or as a substitute for opiates. What are the risks associated with this herbal beverage?Medscape Pharmacists (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 28, 2017 Category: Drugs & Pharmacology Tags: Pharmacist Ask the Expert Source Type: news

CBO: Amended ACA Replacement Bill Doesn't Improve Coverage CBO: Amended ACA Replacement Bill Doesn't Improve Coverage
The bill still will increase the number of uninsured by 24 million by 2026, the CBO said. Meanwhile, a vote scheduled for today has been delayed.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 24, 2017 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Alert Source Type: news

Trump Nominates Scott Gottlieb, MD, to Head FDA Trump Nominates Scott Gottlieb, MD, to Head FDA
Scott Gottlieb, MD, has broad experience in public policy, government service, and drug development, but critics question his extensive ties to industry.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 11, 2017 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Alert Source Type: news

As US Rx Drug Costs Rise, International Pharmacies Beckon As US Rx Drug Costs Rise, International Pharmacies Beckon
More and more patients are heading to the borders to escape the doughnut hole-sized gap in their wallets.Medscape Optometry (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 8, 2017 Category: Drugs & Pharmacology Tags: Commentary Source Type: news

Emerging Drug-Resistant Gonorrhea: What's New and What Now? Emerging Drug-Resistant Gonorrhea: What's New and What Now?
We are starting to lose our last line of defense against drug-resistant gonorrhea. What can be done?CDC Expert Commentary (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 6, 2017 Category: Drugs & Pharmacology Tags: Infectious Diseases Commentary Source Type: news

How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the'critical window'hypothesis of hormone therapy after menopause.Medscape Ob/Gyn (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 28, 2017 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

FDA Expands Use of PCT Test to Guide ABX Use in Respiratory Infections FDA Expands Use of PCT Test to Guide ABX Use in Respiratory Infections
The Vidas Brahms PCT assay can help determine whether antibiotic treatment should be started or stopped in cases of lower respiratory tract infections and stopped in cases of sepsis.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 25, 2017 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

FDA Expands Use of Procalcitonin Test to Help Guide ABX Use FDA Expands Use of Procalcitonin Test to Help Guide ABX Use
The Vidas Brahms PCT assay can help determine whether antibiotic treatment should be started or stopped in cases of lower respiratory tract infections and stopped in cases of sepsis.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 24, 2017 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

Fasting Recommendations for Insulin-Dependent Diabetes Fasting Recommendations for Insulin-Dependent Diabetes
Can patients with insulin-dependent diabetes safely fast for medical or religious reasons?Medscape Pharmacists (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 15, 2017 Category: Drugs & Pharmacology Tags: Pharmacist Ask the Expert Source Type: news

PRAC: Selexipag Under Review, Starts Antibiotic Safety Review PRAC: Selexipag Under Review, Starts Antibiotic Safety Review
PRAC advises continued use of selexipag (Uptravi), on the basis of preliminary data review; launches review of long-lasting side effects with quinolone and fluoroquinolone antibiotics.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 10, 2017 Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Alert Source Type: news